Dara Wright - Sep 1, 2022 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
Executive Vice President
Signature
/s/ Dara Wright
Stock symbol
BIO
Transactions as of
Sep 1, 2022
Transactions value $
-$68,561
Form type
4
Date filed
9/6/2022, 02:12 PM
Previous filing
Dec 17, 2021
Next filing
Sep 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +405 +44.36% $0.00 1.32K Sep 1, 2022 Direct F1, F2
transaction BIO Bio-Rad A Common Stock Tax liability -$68.6K -141 -10.7% $486.25 1.18K Sep 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Award $0 +2.08K $0.00 2.08K Sep 1, 2022 Bio-Rad A Common Stock 2.08K $0.00 Direct F3, F4
transaction BIO Restricted Stock Units Options Exercise $0 -405 -24.98% $0.00 1.22K Sep 1, 2022 Bio-Rad A Common Stock 405 $0.00 Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 20.8996 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2022.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F5 On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.